Screening for Human Papillomavirus-Driven Oropharyngeal Cancer: Considerations for Feasibility and Strategies for Research
Screening for Human Papillomavirus-Driven Oropharyngeal Cancer: Considerations for Feasibility and Strategies for Research
复制标题
DOI:
10.1002/cncr.31256
复制
发表时间:
2018-05-01
期刊:
影响因子:
6.2
通讯作者:
Waterboer, Tim
中科院分区:
文献类型:
--
作者:
Kreimer, Aimee R.;Shiels, Meredith S.;Waterboer, Tim
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.